Green MF - Search Results

1

A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia.

Buchanan RW, Davis M, Goff D, Green MF, Keefe RS, Leon AC, Nuechterlein KH, Laughren T, Levin R, Stover E, Fenton W, Marder SR. Buchanan RW, et al. Among authors: green mf. Schizophr Bull. 2005 Jan;31(1):5-19. doi: 10.1093/schbul/sbi020. Epub 2005 Feb 16. Schizophr Bull. 2005. PMID: 15888422

2

Sustained and selective attention in schizophrenia.

Green MF, Nuechterlein KH, Gaier DJ. Green MF, et al. Prog Exp Pers Psychopathol Res. 1992;15:290-313. Prog Exp Pers Psychopathol Res. 1992. PMID: 1343109 No abstract available.

3

The temporal relationship between depressive and psychotic symptoms in recent-onset schizophrenia.

Green MF, Nuechterlein KH, Ventura J, Mintz J. Green MF, et al. Am J Psychiatry. 1990 Feb;147(2):179-82. doi: 10.1176/ajp.147.2.179. Am J Psychiatry. 1990. PMID: 2301655

4

The relationship of symptomatology and medication to electrodermal activity in schizophrenia.

Green MF, Nuechterlein KH, Satz P. Green MF, et al. Psychophysiology. 1989 Mar;26(2):148-57. doi: 10.1111/j.1469-8986.1989.tb03147.x. Psychophysiology. 1989. PMID: 2567035

5

Neuroleptic effects on electrodermal responsivity to soft tones and loud noise in schizophrenia.

Green MF, Nuechterlein KH. Green MF, et al. Psychiatry Res. 1988 Apr;24(1):79-86. doi: 10.1016/0165-1781(88)90143-6. Psychiatry Res. 1988. PMID: 2899332

6

Information-processing abnormalities as neuropsychological vulnerability indicators for schizophrenia.

Nuechterlein KH, Dawson ME, Green MF. Nuechterlein KH, et al. Among authors: green mf. Acta Psychiatr Scand Suppl. 1994;384:71-9. doi: 10.1111/j.1600-0447.1994.tb05894.x. Acta Psychiatr Scand Suppl. 1994. PMID: 7879647 Review.

7

Backward masking in schizophrenia and mania. I. Specifying a mechanism.

Green MF, Nuechterlein KH, Mintz J. Green MF, et al. Arch Gen Psychiatry. 1994 Dec;51(12):939-44. doi: 10.1001/archpsyc.1994.03950120011003. Arch Gen Psychiatry. 1994. PMID: 7979881

8

Backward masking in schizophrenia and mania. II. Specifying the visual channels.

Green MF, Nuechterlein KH, Mintz J. Green MF, et al. Arch Gen Psychiatry. 1994 Dec;51(12):945-51. doi: 10.1001/archpsyc.1994.03950120017004. Arch Gen Psychiatry. 1994. PMID: 7979882

9

Backward masking performance in unaffected siblings of schizophrenic patients. Evidence for a vulnerability indicator.

Green MF, Nuechterlein KH, Breitmeyer B. Green MF, et al. Arch Gen Psychiatry. 1997 May;54(5):465-72. doi: 10.1001/archpsyc.1997.01830170091012. Arch Gen Psychiatry. 1997. PMID: 9152100

10

Does risperidone improve verbal working memory in treatment-resistant schizophrenia?

Green MF, Marshall BD Jr, Wirshing WC, Ames D, Marder SR, McGurk S, Kern RS, Mintz J. Green MF, et al. Am J Psychiatry. 1997 Jun;154(6):799-804. doi: 10.1176/ajp.154.6.799. Am J Psychiatry. 1997. PMID: 9167507 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

513 results

Search Page

Filters